“Reports of intravenous bolus and continuous infusion studies in rats and dogs up to 4-week duration were available.”
✓ VerifiedFDA pharmacology/toxicology review, p. 58Source ↗
Pivotal GLP studies
4-week i.v. bolus studies in rats and dogs and a 4-week continuous i.v. infusion study in dogs
“In addition to a single dose 24-hr infusion study conducted by AOP Health, a 4-week i.v. bolus study in rats and dogs and a continuous infusion study of the same duration in dogs with ONO-1101 were cited.”
✓ VerifiedFDA pharmacology/toxicology review, p. 21Source ↗
Route in tox
Intravenous (bolus and continuous infusion)
“Most of the toxicity studies conducted with ONO-1101 that the applicant cited were conducted with daily intravenous bolus doses, while intravenous infusion is recommended for the clinical use.”
✓ VerifiedFDA pharmacology/toxicology review, p. 11Source ↗